Click image to view it in full size

Direct-to-consumer genetic testing (DTC-GT) allows individuals to have their DNA tested without having to consult a healthcare provider. DTC-GT can provide insight into various aspects about an individual, including their health and ancestry. Genomic testing has proven to be a revolutionary tool in medicine, in the recent times. Personalised medicine, also called as precision medicine has enable physicians make the best therapeutic choice by facilitating predictions about whether the person will benefit from the medicine or suffer its side effects. Biomarkers and companion diagnostics are increasingly being included in FDA labeling of pharmaceuticals to guide therapy selection, a trend that is expected to accelerate, establishing genomic testing as a mainstay in the clinic. The Hybrid DTC model has successfully improved access and addressed the gap between the conventional DTC-GT model (test patient can complete at home without a healthcare provider) and Traditional Lab Model. Access this research to get insight of Frost and Sullivan’s Patient Centric Market Model, twenty three top companies’ product mapping and opportunities in genetic testing market, including Telegentic counselling which is poised to revolutionize access to patient care.

Advances in genome sequencing technology have enabled rapid growth in genomics research since the first sequencing of the human genome. As the price of genome sequencing has dropped over time, and the technology has become more accessible to the public, direct-to-consumer genetic testing (DTC-GT) has emerged as a new service. DTC-GT, also known as at-home testing, entails genetic testing services that are marketed directly to consumers and enable individuals The Hybrid DTC model has successfully improved access and addressed the gap between the conventional DTC-GT model and the Traditional Lab Model. This new market for genomics services has stirred debates about genetic privacy and identity, as there are potential risks and ethical issues associated with DTC-GT. Despite this concern, Direct-to-consumer testing is expanding the number of people who are able to get genetic testing of their DNA (or genome).Access this research to gain insight of Frost and Sullivan’s Patient Centric market model, and growth levers including Telegentic counselling which is poised to revolutionize access to patient care.